The Relationship Between Cystatin C and SYNTAX Score in Patients Undergoing Coronary Angiography for ST-elevation Myocardial Infarction
1Department of Cardiology, Harran University Faculty of Medicine, Şanlıurfa, Türkiye
Keywords: SYNTAX score; ST-elevation myocardial infarction; cystatin C
Introduction: The SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score (SS) is an angiographic scoring system to determine the severity of coronary artery disease (CAD). As far as we know, studies examining the relationship between SYNTAXscore and cystatin C (Cys-C) are limited in the literature. In this study, we aimed to investigate the relationship between Cys-C level and SS in patients presenting with ST-elevation myocardial infarction (STEMI).
Patients and Methods: One hundred ninety-two patients who underwent coronary angiography for STEMI between June 2021 and December 2021 in our center were included in the study. The patients were divided into two groups according to their SSvalues: Group 1 as patients with SS<22, group 2 as patients with SS≥22. The two groups were compared in terms of baseline characteristics and serum Cys-C levels.
Results: Compared with Group 1, patients in Group 2 had significantly higher Cys-C levels (1.7 ± 0.53 vs 1.3 ± 0.29; p= 0.006). In the correlation analysis, SS showed a positive correlation with the Cys-C level (r= 0.189, p= 0.015). Multivariate logistic regression analysis showed that Cys-C level was an independent predictor of high SS (β= 0.306, p= 0.006). When receiver operating characteristic (ROC) curve analysis is performed, the optimal cut-off value of Cys-C to predict severe coronary artery disease (indicate high SS) is Cys-C≥1.56; was predictive for severe coronary artery disease with 74% sensitivity and 72% specificity [area under the curve (AUC)= 0.745, 95% confidence interval (CI)= 0.624-0.835, p<0.001].
Conclusion: Cystatin C level is independently strongly associated with high SS in STEMI patients. In summary, our results showed that Cys-C is a promising clinical biomarker that can be used to assess the severity of coronary artery lesions, which may provide complementary information for established risk markers.